ESPN’s T.J. Quinn was a beat writer for many years, covering the White Sox and Mets and then moved on to do investigative reporting for the New York Daily News and ESPN, with a huge emphasis on covering performance enhancing drugs in sports. If there is any Hall of Fame voter, therefore, who is qualified to assess how PEDs and the Hall of Fame mix, it’s him.
Except he has decided that even he can’t do it and gave up voting for the Hall of Fame two years ago. Today he explains why:
Even before the issue of performance-enhancing drugs overwhelmed the annual conversation, I questioned my capacity to evaluate a player’s fitness for immortality. My only qualification, like all voters, was 10 years’ service as a BBWAA member. But nothing in my years as a beat writer covering the Chicago White Sox and New York Mets, and nothing in my years covering doping as an investigative reporter since has prepared me to evaluate the effect PED use should have on a player’s legacy.
He goes on to explain why the “keep the juicin’ bums out” arguments are essentially incoherent as generally applied. He also notes — as we have noted here at HBT lately — that it’s kind of a problem to give votes to guys who haven’t actively covered the game in years. Personally I think Quinn is eminently qualified, but even he himself thinks the fact that he hasn’t covered baseball on a day-to-day basis since 2002 prevents him from being up to the task. So who is?
But at the end of the day, the game, the Hall and journalism would be better served if voting was limited to a select group of veterans, historians and even journalists — if they’re the right journalists. Columnists and national writers who have devoted their careers to the game, not dabblers. That wouldn’t solve the problem of how to evaluate players in the age of modern chemistry, but at least the right group would be making the call.
I think it would be hard to come up with the right group of voters — ex-players are a particular problem as I think they are among the least suited to objectively analyze players’ contributions — but I think Quinn is right that the current electorate — ten-year BBWAA veterans who, quite often, aren’t even baseball writers anymore — is the wrong crop.
A lot of food for thought here. It’s nice to see someone with the franchise chewing on it all, even if he chooses not to vote.
CC Sabathia pitched wonderfully Wednesday night, tossing seven shutout innings in what was easily his best start in ages. But since we live in a world in which we simply cannot have nice things, that sweet has to come with some sour: the Yankees just announced that they have placed Sabathia on the 15-day disabled list with a strained groin.
The Yankees have replaced Sabathia on the roster with their old friend Phil Coke, whose contract they just purchased from Scranton.
The Yankees have had bad luck with all of their starters not named Masahiro Tanaka so far this year. Losing one of them just as he put together his best start of the season is just a killer.
When a pitcher doesn’t sign anywhere before or during spring training people sometimes wring their hands a bit, but it’s usually the case that they’ll be OK if they are patient. Once the season starts guys start going down with injuries left and right or show that they’re ineffective. In such cases, a free agent pitcher’s value goes way up. He’s a relatively low cost option for a team which, a month ago, seemed set but is now suddenly desperate.
Tim Lincecum may benefit from that dynamic.
As we noted earlier today, the Angels’ rotation is a hot mess now that Garrett Richards is out for the year and Andrew Heaney‘s absence may be just as extended. The back end of the Giants’ rotation is likewise a mess. Lincecum was never seriously on San Francisco’s radar this past winter, but given how Matt Cain and Jake Peavy are going, those crazy kids may get back together. The Dodgers could use a pitcher and their competition with the Giants may make this whole situation a lot more profitable for Lincecum than it might have otherwise been.
Of course, Lincecum still has to show that he can pitch and that he’s healthy. That’s why he’s having the showcase, that goes down here very shorty — 2:30 eastern time — and you can watch it streaming live at CSNBayArea.com.
The Braves have been terrible with respect to replay challenges this year. Almost improbably terrible. Fredi Gonzalez has challenged calls seven times and he’s been unsuccessful on all seven challenges. Given how these things work, it’s likely because he’s getting bad advice from the Braves employee designated to watch the replays and suggest when challenges should be made.
Now Gonzalez is going to have a new guy in that role. A familiar name too: Buddy Carlyle, who Mark Bowman of MLB.com reports, will join the Braves as a coaching assistant who will handle the replay review decisions.
Carlyle, of course, spent nine seasons as a major league pitcher and nearly 20 as a professional overall. Most recently with the Mets last season before calling it a career. He pitched for the Braves as well, from 2007-09.
Now he’ll provide a new and, hopefully, more discerning set of eyes for the Braves’ replay operation.
Bad, bad news for the Los Angeles Angels: their best starter needs Tommy John surgery and their most promising young starter has UCL damage as well.
Jeff Passan reports that Garrett Richards has a torn right ulnar collateral ligament and is expected to need Tommy John surgery. Richards was scratched from today’s start due to fatigue and dehydration, but Passan says they found the UCL tear while examining him yesterday. Richards is the Angels’ ace, having won 13 games in 2014 and 15 games a year ago. So far this year he a 2.34 ERA in six starts.
Heaney, meanwhile, has damage to his left ulnar collateral ligament, Passan reports. He was diagnosed with a flexor muscle strain after he was placed on the disabled list following his first start of the season, but this is obviously more serious. Unlike Richards, the plan at the moment is for Heaney to rehab rather than go under the knife. Sometimes that works. Often it doesn’t and Tommy John happens later. We’ll see.
These twin blows are huge and terrible for the Angels, who already had serious depth issues basically everywhere on the roster. The conventional wisdom before the year started was that, if everything broke right and everyone stayed healthy, they could possibly contend in an often volatile AL West, but that they didn’t have a big margin for error. This is a lot of error. The Angels are 13-15 and four games out in the division as it is. Without two starters on whom they were counting big, it’s hard to see how the rest of the Angels’ season isn’t going to be a total slog.